Geraldine Pannu serves as Executive at Processa Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Geraldine Pannu has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 16, 2024 involved exercising options for 800 shares valued at $0.
Geraldine Pannu currently holds 2,200 shares of Processa Pharmaceuticals, Inc. (PCSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Geraldine Pannu has been a net neutral trader of PCSA stock. They have purchased $0 and sold $0 worth of shares.
Geraldine Pannu's most recent insider trade was on May 16, 2024, when they sold 800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 10, 2023 | PCSA | $945 | Award | 4,500 | $0.21 | Discretionary |
| Jun 27, 2023 | PCSA | $0 | Option Exercise | 23,636 | $N/A | Discretionary |
| Jan 18, 2023 | RBB | $0 | Option Exercise | 800 | $N/A | Discretionary |
| Dec 31, 2022 | PCSA | $0 | Option Exercise | 18,208 | $N/A | Discretionary |
| Aug 5, 2022 | PCSA | $0 | Option Exercise | 1,169 | $N/A | Discretionary |
| Mar 31, 2022 | PCSA | $0 | Award | 4,393 | $N/A | Discretionary |
| Aug 5, 2021 | PCSA | $0 | Award | 1,169 | $N/A | Discretionary |